Kevin Starr

Mr. Kevin P.
Starr was previously employed as a Co-Founder by Decibel Therapeutics, Inc., an Independent Director by MyoKardia, Inc., a Chairman by SAGE Therapeutics, Inc., a Chairman by Afferent Pharmaceuticals, Inc., a Chairman by Agios Pharmaceuticals, Inc., a Founding Partner by Third Rock Ventures LLC, an Independent Director by Zafgen, Inc., an Independent Director by Alnylam Pharmaceuticals, Inc., a Chief Operating & Financial Officer by Takeda Oncology Co., a Controller by Biogen MA, Inc., a Principal by Digital Equipment Corp., and an Independent Director by Konarka Technologies, Inc. He also served on the board at Global Blood Therapeutics, Inc., Human Genome Sciences, Inc., Ember Therapeutics, Inc. /Old/, PanOptica, Inc. and Vitae Pharmaceuticals LLC.
He received his undergraduate degree from Colby College and a graduate degree from Boston College.